Hexagon Bio Inc.
Novel payload mechanisms for antibody-drug conjugates (ADCs)
- Sector
- Biotech
- Headquarters
- MENLO PARK, CA
- Founded
- 2016
- Latest Form D
- $67.3M, Oct 2022
- Total capital
- $149M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $149M
- 4 Form D · last Oct 2022
- 49 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 5 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$67.3M
- Private capital raisedForm D · SEC · 3rd filing$61M
- Private capital raisedForm D · SEC · 2nd filing$12M
- Private capital raisedForm D · SEC · 1st filing$8.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Alex Bell KolichDirectorNamed in SEC Form D filings
- Alex T KolicichDirectorNamed in SEC Form D filings
- Brian T. NaughtonExecutive Officer, DirectorNamed in SEC Form D filings
- Colin James Bell HarveyDirectorNamed in SEC Form D filings
- David T GoeddelDirectorNamed in SEC Form D filings
- Jakob T LovenDirectorNamed in SEC Form D filings
Show all 9 people
- Juan JaenDirectorNamed in SEC Form D filings
- Maureen E HillenmeyerExecutive Officer, DirectorNamed in SEC Form D filings
- Mridula T RayDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 5- PendingAntibody Drug Conjugates And Uses ThereofUSPTOApplication PCTUS2025026057
- PendingAntibody Drug Conjugates And Uses ThereofUSPTOApplication 63735245
- PendingMethods For Identification Of Compound Interaction Partners And Compounds Produced By Gene ClustersUSPTOApplication PCTUS2024054936
Show all 5 patent records
- Antibody Drug Conjugates And Uses ThereofApplication PCTUS2025026057Pending
- Antibody Drug Conjugates And Uses ThereofApplication 63735245Pending
- Methods For Identification Of Compound Interaction Partners And Compounds Produced By Gene ClustersApplication PCTUS2024054936Pending
- Antibody Drug Conjugates And Uses ThereofApplication 63637497Pending
- Methods For Identification Of Compound Interaction Partners And Compounds Produced By Gene ClustersApplication 63597058Pending
Related companies, and why
- SonoTheraSimilar federal contract value in Biotech · null in contracts
- Entrada TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Pelage PharmaceuticalsSimilar federal contract value in Biotech · null in contracts
- Dovetail Genomics, LLCSimilar federal contract value in Biotech · null in contracts
- SimBioSys, Inc.Similar federal contract value in Biotech · null in contracts
- Xilio TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .